CLICK HERE FOR THOUSANDS OF FREE BLOGGER TEMPLATES »

Tuesday, March 29, 2022

Moderna Vaccine Patented 9 Months Before Pandemic

Moderna Vaccine Patented 9 Months Before Pandemic. Thanks to the Fauci-Baric’ Manmade SARS Viruses

 

On the cover image the SARS masterminds Anthony Fauci and Ralph Baric beside the hot patent

by Fabio Giuseppe Carlo Carisio

VERSIONE IN ITALIANO

A disturbing document had already emerged proving the existence of an experimental gene serum based on messenger RNA against Covid-19 on 12 December 2019.

But nothing appears compared to the terrible secrets about the Spikevax vaccine produced by Big Pharma Moderna in Cambridge (Massachusetts, USA) thanks to the money of the Bill & Melinda Gates Foundation, the Pentagon (the American Department of Defense) and the collaboration with the Niaid (Institute Allergy and Infectious Diseases National Park) headed by Anthony Fauci, White House advisor on the SARS-Cov-2 pandemic.

Patent US10702600 for the vaccine candidate mRNA-1273 was in fact registered in its new composition on March 28, 2019.

That is 9 months before the official outbreak of the Covid-19 pandemic in China and the availability of the official Wuhan sequence MN908947.1, the virus initially called 2019-nCoV and then renamed by the World Health Organization SARS-Cov-2 to the strong genomic identity with SARS of 2003 (Severe Acute Respiratory Syndrome, or Severe Acute Respiratory Syndrome, when virus and disease were called the same).

Read more 

Be the first to Comment.

Blogger's note:  subterrnews.blogspot.com does not send cookies, or collect any information on those using the blog.  However, the blogspot is on google, and google may collect information, and send cookies.  Many of the links that  we connect to do not send out cookies or collect information, but some do.  You are keying in to this blog, and you have agreed to this.

The views of the author do not necessarily represent the opinions of this blog.  They are the views, and opinions of the author(s) of the article.

 


0 comments: